What does PHARMANDERLECHT do?

PHARMANDERLECHT is a pharmacy in Anderlecht. Private Limited, started on 15 September 2009, 1 establishment.

What is the address of PHARMANDERLECHT?

The registered office of PHARMANDERLECHT is located at Henri Reysquare 3, 1070 Anderlecht.

Is PHARMANDERLECHT still active?

Yes. According to the CBE (31 October 2026) PHARMANDERLECHT is active, legal situation “Normale toestand”, started on 15 September 2009.

Is PHARMANDERLECHT registered on Peppol?

Yes, PHARMANDERLECHT is registered on the Peppol network with ID 0208:0818545386.

What is the enterprise number of PHARMANDERLECHT?

The enterprise number of PHARMANDERLECHT is BE0818545386.

When was PHARMANDERLECHT founded?

PHARMANDERLECHT was founded on 15 September 2009.

Who are the directors of PHARMANDERLECHT?

According to the 2025 annual accounts, the directors of PHARMANDERLECHT are: GOODHEAL SRL.

Is PHARMANDERLECHT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 September 2009; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMANDERLECHT make in 2025?

PHARMANDERLECHT recorded a loss after taxes of € 15,966 in financial year 2025.

What is the revenue of PHARMANDERLECHT?

As a small company, PHARMANDERLECHT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 231,718.

How much does an employee at PHARMANDERLECHT earn?

The average wage cost per full-time employee at PHARMANDERLECHT was € 71,200 in 2025: staff costs of € 227,781 for 3.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMANDERLECHT have?

According to the 2025 annual accounts, PHARMANDERLECHT has 3.2 full-time equivalents (FTE).

Does PHARMANDERLECHT have a website?

Yes, PHARMANDERLECHT has a website at pharmanderlecht.be.

PHARMANDERLECHT (Private Limited) - Anderlecht

Dossier PHARMANDERLECHT, printed on 31 October 2026 from databakkes.be/en/0818545386/pharmanderlecht. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMANDERLECHT from Anderlecht, company number BE0818545386, closed financial year 2025 with a result of € -15,966 after tax. For that financial year PHARMANDERLECHT recorded a gross margin of € 231,718 and equity of € 130,809. Compared with financial year 2024, the result moved from € 50,718 to € -15,966. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 12, 2026.

What it is worth Healthy

€ 130,809

▼ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -15,966

▼ still € 50,718 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 73,756

▲ 84% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 118,409.

People and assets in 2025

Full-time equivalents

3.2

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 227,781

▲ 3% vs 2024

€ 71,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 25

▼ € 42,478 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 97,328

▲ 13% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 37,572

▲ 37% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 299,488 Gross margin 2022: € 299,488 First fiscal year in the series	€ 316,038 Gross margin 2023: € 316,038 ▲ 6% vs 2022 (€ 299,488) Favourable step	€ 308,055 Gross margin 2024: € 308,055 ▼ 3% vs 2023 (€ 316,038) Unfavourable step	€ 231,718 Gross margin 2025: € 231,718 ▼ 25% vs 2024 (€ 308,055) Unfavourable step	▼ 25%
Profit after taxes	€ 64,798 Profit after taxes 2022: € 64,798 First fiscal year in the series	€ 64,706 Profit after taxes 2023: € 64,706 Unchanged (€ 64,798) Unfavourable step	€ 50,718 Profit after taxes 2024: € 50,718 ▼ 22% vs 2023 (€ 64,706) Unfavourable step	€ -15,966 Profit after taxes 2025: € -15,966 ▼ € 66,684 vs 2024 (€ 50,718) Unfavourable step	▼ € 66,684
Equity	€ 31,351 Equity 2022: € 31,351 First fiscal year in the series	€ 96,057 Equity 2023: € 96,057 ▲ 206% vs 2022 (€ 31,351) Favourable step	€ 146,775 Equity 2024: € 146,775 ▲ 53% vs 2023 (€ 96,057) Favourable step	€ 130,809 Equity 2025: € 130,809 ▼ 11% vs 2024 (€ 146,775) Unfavourable step	▼ 11%
Total debts	€ 268,349 Total debts 2022: € 268,349 First fiscal year in the series	€ 205,156 Total debts 2023: € 205,156 ▼ 24% vs 2022 (€ 268,349) Favourable step	€ 147,369 Total debts 2024: € 147,369 ▼ 28% vs 2023 (€ 205,156) Favourable step	€ 173,519 Total debts 2025: € 173,519 ▲ 18% vs 2024 (€ 147,369) Unfavourable step	▲ 18%
Cash	€ 107,728 Cash 2022: € 107,728 First fiscal year in the series	€ 84,513 Cash 2023: € 84,513 ▼ 22% vs 2022 (€ 107,728) Unfavourable step	€ 40,038 Cash 2024: € 40,038 ▼ 53% vs 2023 (€ 84,513) Unfavourable step	€ 73,756 Cash 2025: € 73,756 ▲ 84% vs 2024 (€ 40,038) Favourable step	▲ 84%
Retained profit	€ 18,951 Retained profit 2022: € 18,951 First fiscal year in the series	€ 83,657 Retained profit 2023: € 83,657 ▲ € 64,706 vs 2022 (€ 18,951) Favourable step	€ 134,375 Retained profit 2024: € 134,375 ▲ 61% vs 2023 (€ 83,657) Favourable step	€ 118,409 Retained profit 2025: € 118,409 ▼ 12% vs 2024 (€ 134,375) Unfavourable step	▼ 12%
Bank debt	€ 119,358 Bank debt 2022: € 119,358 First fiscal year in the series	€ 58,886 Bank debt 2023: € 58,886 ▼ 51% vs 2022 (€ 119,358) Favourable step	€ 34,217 Bank debt 2024: € 34,217 ▼ 42% vs 2023 (€ 58,886) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 34,217) Favourable step	▼ 100%
Balance sheet total	€ 299,700 Balance sheet total 2022: € 299,700 First fiscal year in the series	€ 301,213 Balance sheet total 2023: € 301,213 ▲ 1% vs 2022 (€ 299,700) Unchanged	€ 294,144 Balance sheet total 2024: € 294,144 ▼ 2% vs 2023 (€ 301,213) Unchanged	€ 304,329 Balance sheet total 2025: € 304,329 ▲ 3% vs 2024 (€ 294,144) Unchanged	▲ 3%
Employees (FTE)	3.2 Employees (FTE) 2022: 3.2 First fiscal year in the series	3.2 Employees (FTE) 2023: 3.2 Unchanged (3.2) Unchanged	3.2 Employees (FTE) 2024: 3.2 Unchanged (3.2) Unchanged	3.2 Employees (FTE) 2025: 3.2 Unchanged (3.2) Unchanged

Key figures of PHARMANDERLECHT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to PHARMANDERLECHT?

What happened at PHARMANDERLECHT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 12, 2026 New annual accounts for financial year 2025: loss of € 15,966 (▼ € 66,684 vs 2024). Source: NBB ↗
Oct 1, 2009 New establishment in Anderlecht. KBO
Sep 15, 2009 Start of the company according to the CBE. KBO

In short

From € 64,798 profit in 2022 to € 15,966 loss in 2025.

Paid € 51,676 in corporate taxes since 2022.

Best year ever: 2022, with € 64,798 profit.

On average € 72,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

GOODHEAL 100%

The stake of GOODHEAL comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMANDERLECHT

Behind PHARMANDERLECHT is GOODHEAL SRL. The shares are held by GOODHEAL (100%).

Directors

According to the 2025 annual accounts

GOODHEAL SRL

Director · represented by MOMO GERSONIE

Also active at: PHARMACIE DES FLEURISTES

Shareholders

GOODHEAL

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Henri Reysquare 3

1070 Anderlecht

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS pharmanderlecht.be

Hosting & Email

Email provider

OVH Mail

Hosting

OVH, FR

DNS

OVH DNS

Domain

pharmanderlecht.be

Registered

2009-09-30

Website info

HTTPS Ja

Features

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number: 0818.545.386
VAT number: BE 0818.545.386
Registered office: Henri Reysquare 3, 1070 Anderlecht
Names & denominations: PHARMANDERLECHT
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 15 September 2009
Peppol: Active · Active since 12 Feb 2026
Contact: pharmanderlecht.be
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗